Zeposia Kit
Product Images NDC 59572-890

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Zeposia (NDC 59572-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zeposia 01)

Chemical structure of ozanimod hydrochloride, the active ingredient in ZEPOSIA capsules. The diagram shows the molecular arrangement of atoms and bonds specific to ozanimod hydrochloride.*

FDA Label Image

Principal Display Panel (0.92 mg Capsule Bottle Label)

Label for ZEPOSIA (ozanimod hydrochloride) capsules, 0.92 mg strength, manufactured by Celgene Corporation. The label displays the product name, strength, capsule count of 30, and includes dosage information, storage instructions, and the National Drug Code (NDC 59572-820-30). It also specifies prescription status and manufacturer details.*

FDA Label Image

Zeposia 02a

ZEPOSIA 0.92 mg oral capsules label, containing ozanimod hydrochloride. The label shows sample status (Not For Sale) and specifies a package of 30 capsules. It includes storage instructions, manufacturing details by Celgene Corporation, and NDC 59572-820-99.*

FDA Label Image

Principal Display Panel (7 Capsule Starter Pack Kit Carton)

ZEPOSIA (ozanimod) capsules 7-day starter pack packaging label. The label states it contains 7 capsules for 7 days of dosing with capsules of 0.23 mg and 0.46 mg strengths. The label includes dosing instructions, storage information, manufacturer Celgene Corporation, and a National Drug Code (NDC 59572-810-07). The design features the ZEPOSIA logo and brand colors.*

FDA Label Image

Principal Display Panel (7 Capsule Blister Pack)

ZEPOSIA (ozanimod) capsules 7-day starter pack packaging label showing detailed blister card with capsules and day-wise dosing instructions. The pack includes capsules of 0.23 mg and 0.46 mg strengths arranged for a 7-day oral dosing schedule. Labeler is Celgene Corporation, and the image includes step-by-step opening instructions and NDC 59572-810-07.*

FDA Label Image

Principal Display Panel (Kit Carton)

ZEPOSIA (ozanimod) capsules Starter Kit packaging label for oral capsules by Celgene Corporation. The label indicates a titration starter kit with instructions for dosing over 7 days, progressing to a maintenance dose of 0.92 mg capsules. The kit contains 37 capsules including 0.23 mg, 0.46 mg, and 0.92 mg capsule strengths. The packaging includes directions for use, a barcode, and manufacturer information.*

FDA Label Image

Principal Display Panel (0.92 mg Capsule Bottle Label)

ZEPOSIA (ozanimod) capsules 0.92 mg oral capsules packaging label from Celgene Corporation. The label displays the dosage strength of 0.92 mg and indicates a package of 30 capsules. It includes storage instructions, dosing guidance notes, and a barcode. The product is marked 'Not To Be Sold Separately' and is for prescription use only.*

FDA Label Image

Principal Display Panel (7 Capsule Blister Pack)

ZEPOSIA (ozanimod) capsules 0.23 mg and 0.46 mg oral dosage form, presented in a 7-day starter pack by Celgene Corporation. The packaging includes detailed dosing instructions for a 7-day titration schedule, blister pack with capsules labeled by day and strength, and pictorial instructions for opening. The pack contains seven capsules: four at 0.23 mg and three at 0.46 mg, with clear labeling emphasizing "Not to be sold separately."*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for ZEPOSIA (ozanimod) capsules, 0.92 mg strength, oral capsules by Celgene Corporation. The label displays directions for a 7-day starter pack with varying capsule doses and instructions for maintenance dosing thereafter. It includes sample warnings, lot and expiration placeholders, the NDC 59572-890-97, barcodes, and Celgene branding.*

FDA Label Image

Principal Display Panel (0.92 mg Capsule Bottle Label)

ZEPOSIA 0.92 mg capsules packaging label showing the generic name ozanimod hydrochloride, NDC 59572-820-97. The label includes a sample notice 'NOT FOR SALE,' manufacturer Celgene Corporation, and storage instructions. The package contains 30 capsules for oral use with prescription only indication.*

FDA Label Image

Principal Display Panel (7 Capsule Blister Pack)

ZEPOSIA (ozanimod) capsules 7-day pack labeling from Celgene Corporation, featuring detailed 7-day dosing instructions with daily capsule dosages of 0.23 mg and 0.46 mg. The carton includes illustrations on how to open capsules and phased dosage schedule for days 1 through 7, clearly marked for sample use and not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.